Suraksha Diagnostic [SURAKSHA] vs Qualitek Labs [QLL] Detailed Stock Comparison

Suraksha Diagnostic
NSE
Loading...

Qualitek Labs
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Suraksha Diagnostic wins in 6 metrics, Qualitek Labs wins in 10 metrics, with 0 ties. Qualitek Labs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Suraksha Diagnostic | Qualitek Labs | Better |
---|---|---|---|
P/E Ratio (TTM) | 49.87 | 42.74 | Qualitek Labs |
Price-to-Book Ratio | 7.35 | 3.10 | Qualitek Labs |
Debt-to-Equity Ratio | 42.28 | 37.74 | Qualitek Labs |
PEG Ratio | 1.58 | N/A | N/A |
EV/EBITDA | 18.56 | 20.89 | Suraksha Diagnostic |
Profit Margin (TTM) | 12.43% | 8.97% | Suraksha Diagnostic |
Operating Margin (TTM) | 18.33% | 20.77% | Qualitek Labs |
EBITDA Margin (TTM) | 18.33% | 20.77% | Qualitek Labs |
Return on Equity | 15.91% | 12.27% | Suraksha Diagnostic |
Return on Assets (TTM) | 10.25% | 7.19% | Suraksha Diagnostic |
Free Cash Flow (TTM) | $213.35M | $38.67M | Suraksha Diagnostic |
1-Year Return | -28.52% | 3.90% | Qualitek Labs |
Price-to-Sales Ratio (TTM) | 6.07 | 4.30 | Qualitek Labs |
Enterprise Value | $16.20B | $2.80B | Suraksha Diagnostic |
EV/Revenue Ratio | 6.33 | 3.98 | Qualitek Labs |
Gross Profit Margin (TTM) | 86.41% | N/A | N/A |
Revenue per Share (TTM) | $48 | $79 | Qualitek Labs |
Earnings per Share (Diluted) | $5.98 | $7.08 | Qualitek Labs |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Suraksha Diagnostic vs Qualitek Labs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Suraksha Diagnostic | -0.45% | -0.88% | -6.86% | 4.30% | -9.92% | -21.53% |
Qualitek Labs | 4.53% | -4.20% | -3.32% | 3.63% | 8.46% | -17.51% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Suraksha Diagnostic | -28.52% | -28.52% | -28.52% | -28.52% | -28.52% | -28.52% |
Qualitek Labs | 3.90% | 95.48% | 95.48% | 95.48% | 95.48% | 95.48% |
Performance & Financial Health Analysis: Suraksha Diagnostic vs Qualitek Labs
Metric | SURAKSHA | QLL |
---|---|---|
Market Information | ||
Market Cap | ₹15.53B | ₹3.02B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 23,274 | 4,120 |
90 Day Avg. Volume | 42,645 | 7,053 |
Last Close | ₹296.90 | ₹316.30 |
52 Week Range | ₹231.00 - ₹449.00 | ₹215.05 - ₹375.00 |
% from 52W High | -33.88% | -15.65% |
All-Time High | ₹449.00 (Dec 02, 2024) | ₹375.00 (Dec 23, 2024) |
% from All-Time High | -33.88% | -15.65% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.17% | N/A |
Quarterly Earnings Growth | 0.13% | N/A |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.09% |
Operating Margin (TTM) | 0.18% | 0.21% |
Return on Equity (TTM) | 0.16% | 0.12% |
Debt to Equity (MRQ) | 42.28 | 37.74 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹40.60 | ₹97.54 |
Cash per Share (MRQ) | ₹3.86 | ₹1.99 |
Operating Cash Flow (TTM) | ₹633.59M | ₹53.16M |
Levered Free Cash Flow (TTM) | ₹146.11M | ₹76.84M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Suraksha Diagnostic vs Qualitek Labs
Metric | SURAKSHA | QLL |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 49.87 | 42.74 |
Forward P/E | 31.90 | N/A |
PEG Ratio | 1.58 | N/A |
Price to Sales (TTM) | 6.07 | 4.30 |
Price to Book (MRQ) | 7.35 | 3.10 |
Market Capitalization | ||
Market Capitalization | ₹15.53B | ₹3.02B |
Enterprise Value | ₹16.20B | ₹2.80B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 6.33 | 3.98 |
Enterprise to EBITDA | 18.56 | 20.89 |
Risk & Other Metrics | ||
Beta | N/A | N/A |
Book Value per Share (MRQ) | ₹40.60 | ₹97.54 |
Financial Statements Comparison: Suraksha Diagnostic vs Qualitek Labs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SURAKSHA | QLL |
---|---|---|
Revenue/Sales | ₹650.95M | N/A |
Cost of Goods Sold | ₹88.48M | N/A |
Gross Profit | ₹562.47M | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹126.45M | N/A |
EBITDA | ₹221.90M | N/A |
Pre-Tax Income | ₹92.13M | N/A |
Income Tax | ₹20.42M | N/A |
Net Income (Profit) | ₹71.71M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SURAKSHA | QLL |
---|---|---|
Cash & Equivalents | ₹22.47M | ₹51.74M |
Total Current Assets | ₹471.53M | ₹426.08M |
Total Current Liabilities | ₹427.17M | ₹325.84M |
Long-Term Debt | ₹741.03M | ₹308.61M |
Total Shareholders Equity | ₹2.10B | ₹927.82M |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹2.21B | ₹589.98M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SURAKSHA | QLL |
---|---|---|
Operating Cash Flow | ₹148.52M | N/A |
Capital Expenditures | ₹-123.19M | N/A |
Free Cash Flow | ₹64.63M | N/A |
Debt Repayment | ₹-7.29M | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | SURAKSHA | QLL |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 23,274 | 4,120 |
Average Daily Volume (90 Day) | 42,645 | 7,053 |
Shares Outstanding | 52.08M | 9.98M |
Float Shares | 21.54M | 711,777 |
% Held by Insiders | 0.62% | 0.69% |
% Held by Institutions | 0.23% | 0.00% |
Dividend Analysis & Yield Comparison: Suraksha Diagnostic vs Qualitek Labs
Metric | SURAKSHA | QLL |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |